BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2014 5:08:00 PM | Browse: 406 | Download: 331
Publication Name World Journal of Cardiology
Manuscript ID 7699
Country of Manuscript Source Spain
Received
2013-12-02 17:32
Peer-Review Started
2013-12-03 10:44
To Make the First Decision
2013-12-13 13:25
Return for Revision
2013-12-14 17:32
Revised
2013-12-17 04:18
Second Decision
2014-01-20 08:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-01-20 10:01
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-04 04:11
Typeset the Manuscript
2014-03-10 16:29
Publish the Manuscript Online
2014-03-19 18:20
ISSN 1949-8462 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac and Cardiovascular Systems
Manuscript Type Minireviews
Article Title Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era
Manuscript Source Invited Manuscript
All Author List Alberto Dominguez-Rodriguez, Pedro Abreu-Gonzalez and Russel J Reiter
Funding Agency and Grant Number
Funding Agency Grant Number
Framework of one research project of the Spanish Society of Cardiology for Clinical Research in Cardiology 2012
Corresponding author Alberto Dominguez-Rodriguez, MD, PhD, Department of Cardiology, Complejo Hospitalario Universitario de Canarias, Ofra s/n La Cuesta E-, 38320 Tenerife, Spain. adrvdg@hotmail.com
Keywords ST-elevation myocardial infarction; Cardioprotection; Myocardial reperfusion injury; Infarct size; Adjunctive therapy
Core Tip As therapeutic interventions administered at the time myocardial reperfusion have been proven to reduce infarct size in both experimental and clinical models, the existence of a lethal reperfusion injury and its contribution to ischemic cardiac cell death can no longer be ignored. Patients presenting with an acute ST-segment elevation myocardial infarction will likely benefit from therapy aimed at the timely administration of drugs, most likely via primary percutaneous coronary intervention, for the reduction/prevention of lethal reperfusion injury. This approach will ensure that patients maximally benefit from the myocardial salvage that results from these therapies.
Publish Date 2014-03-19 18:20
Citation Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era. World J Cardiol 2014; 6(3): 100-106 Available from: URL: http://www.wjgnet. com/1949-8462/full/v6/i3/100.htm DOI: http://dx.doi. org/10.4330/wjc.v6.i3.100
Url http://www.wjgnet.com/1949-8462/full/v6/i3/100.htm
DOI http://dx.doi.org/10.4330/wjc.v6.i3.100
Full Article (PDF) WJC-6-100.pdf
Full Article (Word) WJC-6-100.doc
Manuscript File 7699-Review.doc
Answering Reviewers 7699-Answering reviewers.pdf
Copyright License Agreement 7699-Copyright assignment.pdf
Peer-review Report 7699-Peer review(s).pdf
Scientific Editor Work List 7699-Scientific editor work list.doc